作者:Takuya Kobayakawa、Kento Ebihara、Kohei Tsuji、Takuma Kawada、Masayuki Fujino、Yuzuna Honda、Nami Ohashi、Tsutomu Murakami、Hirokazu Tamamura
DOI:10.1016/j.bmc.2020.115812
日期:2020.12
protein gp41, has significant anti-HIV activity. Previously, a dimeric derivative of C34 linked by a disulfide bridge at its C-terminus was found to have more potent anti-HIV activity than the C34 peptide monomer. To date, several peptidomimetic small inhibitors have been reported, but most have lower potency than peptide derivatives related to C34. In the present study we applied this dimerization
膜融合是抑制HIV-1复制的有效靶标。HIV-1包膜蛋白gp41中包含的34-mer片段肽(C34)具有显着的抗HIV活性。以前,C34的二聚体衍生物在其C处通过二硫键连接-末端发现比C34肽单体具有更强的抗HIV活性。迄今为止,已经报道了几种拟肽小抑制剂,但是大多数抑制剂的效力低于与C34相关的肽衍生物。在本研究中,我们将此二聚化概念应用于这些拟肽小抑制剂,并设计了几种二价拟肽HIV-1融合抑制剂。证明了交联两个拟肽化合物的接头长度的重要性,并生产了几种有效的含束缚拟肽的二价抑制剂。